Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_4
1
25%
Ph phase_3
1
25%
Ph phase_2
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (33.3%)
Phase 31 (33.3%)
Phase 41 (33.3%)

Trials by Status

completed250%
unknown125%
not_yet_recruiting125%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruitingphase_2

18F-mFBG Imaging for Myocardial Sympathetic Innervation

NCT06965621
unknown

Impact of Coronary Artery Stenting on Quantitative Myocardial Blood Flow and Health Status

NCT04475094
completedphase_4

Characterization of Myocardial Blood Flow Measurements Using Lexiscan®™ (Regadenoson) (Lexiscan®™) Rubidium-82 Myocardial Perfusion PET: A Temporal-Dependency Investigation

NCT01919450
completedphase_3

Rubidium-82 PET and Tc-99m-MIBI SPET: A Head to Head Comparison

NCT01379677

Clinical Trials (4)

Showing 4 of 4 trials
NCT06965621Phase 2

18F-mFBG Imaging for Myocardial Sympathetic Innervation

Not Yet Recruiting
NCT04475094

Impact of Coronary Artery Stenting on Quantitative Myocardial Blood Flow and Health Status

Unknown
NCT01919450Phase 4

Characterization of Myocardial Blood Flow Measurements Using Lexiscan®™ (Regadenoson) (Lexiscan®™) Rubidium-82 Myocardial Perfusion PET: A Temporal-Dependency Investigation

Completed
NCT01379677Phase 3

Rubidium-82 PET and Tc-99m-MIBI SPET: A Head to Head Comparison

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4